The largest database of trusted experimental protocols

Ppackh1 packaging plasmid mix

Manufactured by System Biosciences
Sourced in United States, Canada

The PPACKH1 packaging plasmid mix is a set of plasmids designed for the production of recombinant lentiviral particles. The mix contains the necessary genetic components required for the packaging and assembly of lentiviral particles.

Automatically generated - may contain errors

19 protocols using ppackh1 packaging plasmid mix

1

Generating Stable Cell Lines with Lentiviral Transduction

Check if the same lab product or an alternative is used in the 5 most similar protocols
This cell line was generated by sub-cloning ESR1 wild-type and mutant cDNAs containing an amino terminal hemagglutinin tag into pCDH-EF1-MCS-(PGK-Puro) (System Biosciences). The resulting plasmids, in addition to an empty vector negative control, were subsequently co-transfected into HEK293T cells with the pPACKH1 packaging plasmid mix (System Biosciences) according to the manufacturer’s protocol. After transfection, lentiviral particles were purified from the cell medium, and used to transduce MCF7 cells. Stable cell lines were selected by growth in RPMI containing 10% FBS plus 1 μG/mL puromycin. Following selection, expression of HA-tagged mutant ERα was confirmed by western blot using the 6E2 mouse monoclonal anti-HA antibody (Cell Signaling).
+ Open protocol
+ Expand
2

Overexpression of YY1 in BXPC-3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sunbio Medical Biotechnology Co., Ltd (Shanghai, China) constructed the YY1-overexpression lentiviruses. Briefly, the full-length coding region of human YY1 was subcloned into pCDH-CMV-MCS-EF1-Puro vector (System Biosciences, Mountain View, CA, USA) and verified by sequencing. The verified recombinant vector and the pPACKH1 packaging plasmid mix (System Biosciences) were co-transfected into 293T cells using the Lipofectamine 2000 reagent (Life Technologies). The supernatant of the cultured 293T cells was collected to infect BXPC-3 cells. The pCDH-CMV-MCS-EF1-Puro vector was used to package the virus and infect BXPC-3 cells as a control. Stable cell lines (BXPC-Vector and BXPC-YY1) were selected by culturing in media containing 5 μg/ml puromycin (Sigma). YY1 expression was confirmed by qRT-PCR and Western blot.
+ Open protocol
+ Expand
3

Construction of miR-424 Expression Vector

Check if the same lab product or an alternative is used in the 5 most similar protocols
To construct miR-424 expression vector, two oligonucleotides [5′-TCGACAGCAGCAATTCATGTTTTGAAGTGTGCTGTCCTTCAAAACATGAATTGCTGCTGTTTTT-3′ (forward) and 5′-AATTAAAAACAGCAGCAATTCATGTTTTGAAGGACAGCACACTTCAAAACATGAATTGCTGCTG-3′ (reverse)] were synthesized and cloned into pCDH-CMV lentiviral vector (System Biosciences, Mountain View, CA, USA). Lentiviral expression vectors for UNC5B and SIRT4 were purchased from System Biosciences. 293 T cells were co-transfected with pPackH1 packaging plasmid mix (System Biosciences) and the indicated lentiviral vectors using Fugene HD transfection reagent following the manufacturer’s protocols (Promega). Forty-eight hours after transfection, the lentivirus particles were harvested.
+ Open protocol
+ Expand
4

Doxycycline-Inducible PAX3-FOXO1 Fusion Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PAX3-FOXO1 fusion cDNA was subcloned into the lentiviral doxycycline-inducible pINDUCER10 vector (provided by Dr. J. Luo). A single-guide RNA (sgRNA) targeting the 5′ PAX3 region was designed (Table S1) and cloned into the lentiCRISPR v2 plasmid (provided by Dr. J. Luo) [13 (link)–15 (link)]. Oligonucleotides were purchased from Integrated DNA Technologies. Lentiviral particles were prepared in HEK293T cells with the HIV-based pPACK-H1 Packaging Plasmid Mix (System Biosciences).
+ Open protocol
+ Expand
5

Lentiviral shRNA Construct Synthesis and Pseudoviral Particle Generation

Check if the same lab product or an alternative is used in the 5 most similar protocols
shRNA vectors were constructed using a pSIH-H1-copGFP shRNA vector (System Biosciences) by inserting synthetic oligonucleotides. The following four unique shRNA constructs were then prepared using synthetic oligonucleotides: (1) 5′-AGAGACAGAACCTCCTTCCAGCTACTCAA-3′; (2) 5′-AGGAGTGTCTGGTGACTGAAGTACAGGTC-3′; (3) 5′-AGGCGTCAACAGTACGAGTGTCTTCACTA-3′; and (4) 5′-GTGCGGAGAATCTGACCTGCTGGATTCAT-3′. Pseudoviral particles were generated by cotransfecting a pPACKH1 Packaging Plasmid Mix (System Biosciences) and a mixture of the four pSIH vectors into HEK293TN cells in a 6-well plate using Lipofectamine and Plus Reagent (Life Technologies, Carlsbad, CA, USA), as described previously [16 (link),17 (link)]. For controls, a pSIH-H1-copGFP vector inserted with a scrambled sequence (5′-TAGCGACTAAACACATCAA-3′) that had no homology with any human mRNA (shCont) and no vector [Lenti (−)] was used. Supernatants were collected after 72 h from the cultured medium and used for infection.
+ Open protocol
+ Expand
6

Generating NF-κB Reporter NKL Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
NKL reporter cells (NKL-κB-GFP) that express GFP under the control of NF-κB transcription response elements were generated by transducing NKL cells with lentiviral κB-GFP construct (System Biosciences). Lentiviral particles were produced by simultaneous transfection of 293TN packaging cell line (System Biosciences) with pGreenFire-NF-κB-EF1-Puro vector and pPACKH1 packaging plasmid mix (System Biosciences). NKL cells were transduced with lentivirus supernatant that encodes κB-GFP in the presence of 10 μg ml−1 polybrene and 200 U ml−1 rIL-2 and then selected with 1 μg ml−1 puromycin (2 days after transduction). Thereafter, NKL transductants showing GFP upregulation upon TNF-α treatment were further selected by FACS-sorting and grown as pure cultures. To assess NF-κB activation, NKL-κB-GFP cells were stimulated with TNF-α or plate-immobilized mAbs specific for NK receptors, and GFP expression in the reporter NKL cells was analysed by flow cytometry.
+ Open protocol
+ Expand
7

Lentiviral Transduction of Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For stable transduction of iBMSCs or ASCs with miR-181a overexpression, miR-181a antagomiR, PER3 shRNA and PPARG shRNA lentiviral vectors HEK 293 T cells were cotransfected with the lentiviral expression vector along with pPACKH1 Packaging Plasmid Mix (System Biosciences) according to the manufacturer provided protocol. Both Scp-1 and PASC-1 cells were then transduced with the lentivirus according to the manufacturer provided protocol. For selection of the iBMSCs or ASCs transduced with miR-181a overexpression (both p000 and p181a vectors) and miR-181a antagomiR (both cmiR and antimiR vectors) RFP FACS was used. For selection of the iBMSCs transduced with PER3 shRNA (both shscram and shPER3 #1 & #2 vectors) and PPARG shRNA (both shscram and shPPARG vectors) GFP FACS was used. For the experiments involving PPARG knockdown the Scp-1 p000 cells were transduced with shscram vector (Scp-1 p000-shscram) and the Scp-1 p181a cells were either transduced with either shscram (Scp-1 p181a-shscram) or shPPARG vectors (Scp-1 p181a-shPPARG). These cells were sorted for the dual RFP/GFP+ cells. All cell lines selected with FACS were analyzed every 3–5 passages to make sure that the RFP and/or GFP+ population was >95% with re-sorting done as needed.
+ Open protocol
+ Expand
8

Overexpression of SNORA42 in HEK293T

Check if the same lab product or an alternative is used in the 5 most similar protocols
SNORA42 was cloned as described previously.21 (link) A pCDH vector (System biosciences, Mountain view, CA, USA) was used for ectopic over-expression of SNORA42. The pCDH vector encoding intact sequence of SNORA42 cDNA or empty vector as a control was infected into HEK293T cells together with pPACKH1 Packaging Plasmid mix (System biosciences) for producing viral particles using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). Further information is provided in the Supplementary material and methods.
+ Open protocol
+ Expand
9

Stable Transduction of FTSECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For stable transduction of FTSECs with miR-181a overexpression, miR-181a antagomiR, and RB1 shRNA lentiviral vectors HEK 293T cells were cotransfected with the lentiviral expression vector along with pPACKH1 Packaging Plasmid Mix (System Biosciences) according to the manufacturer provided protocol. FTSECs (passage 5 or earlier) were then transduced with the lentivirus according to the manufacturer provided protocol. For selection of the FTSECs transduced with miR-181a overexpression (both p000 and p181a vectors) RFP flow cytometry was used. For cells transduced with miR-181a antagomiR (both cmiR and antimiR vectors) hygromycin selection was used. Post transduction, cells were selected with 500 μg/mL hygromycin in DMEMF12 for 48 h. After recovery, selection was maintained by treatment with 500 μg/mL hygromycin in DMEMF12 for 48 h every three passages. miR-181a antagomiR transduction efficiency was assessed by qRT-PCR. For selection of the FTSECs transduced with RB1 shRNA GFP flow cytometry was used. All cell lines selected with flow cytometry were analyzed every 3–5 passages to make sure that the RFP or GFP + population was >95% with resorting done as needed.
+ Open protocol
+ Expand
10

MYCN and FGF8b Modulation in Dbt Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dbt cells were previously transduced either with a constitutive MYCN expression construct (Dbt/MYCN) or with MYCN and an inducible P3F expression construct (Dbt/MYCN/iP3F) (5 (link),6 (link)). The pCMV6-Entry vector expressing FGF8b cDNA or the empty vector EV (Origene, Rockville, MD) was stably transfected using lipofectamine 3000 (Thermo Fisher Scientific, Waltham, MA). CRISPR/Cas9 targeting of FGF8 was performed with single-guide RNAs cloned into the lentiCRISPR v2-eGFP (GenScript, Piscataway NJ) and compared with the control non-targeting vector lentiCRISPR v2-eGFP (CR-control). Dbt/MYCN/iP3F cells were transduced with a green fluorescent protein (GFP) expression construct as previously described (6 (link)). Lentiviral particles were packaged using HEK293T cells with the human immunodeficiency virus-based pPACK-H1 Packaging Plasmid Mix (System Biosciences, Mountain View, CA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!